76 Metabolic Heterogeneity in Brain Tumours: Distinguishing Brain Metastases from Glioblastomas
Brain metastases account for nearly 20% of cancer-related deaths and have a five-year survival rate of 2.4%, most commonly arising from breast and lung cancers. Despite therapeutic advances, prognosis remains poor, highlighting the need for novel treatment strategies. Metabolic reprogramming is a hallmark of canc...